These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. HL-A antibodies: influence on the human foetus. Ahrons S Tissue Antigens; 1971; 1(3):129-36. PubMed ID: 5005219 [No Abstract] [Full Text] [Related]
25. [Fetomaternal immunization of pregnant women to HL-A alloantigens and ABO and Rh antigens. II. Clinical observations on the course of pregnancy]. Zdebski Z Folia Med Cracov; 1974; 16(3):341-53. PubMed ID: 4212657 [No Abstract] [Full Text] [Related]
26. [On the prevention of Rh immunization in Sweden]. Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799 [No Abstract] [Full Text] [Related]
27. [Immune-prevention of fetal erythroblastosis]. Schubert W Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879 [No Abstract] [Full Text] [Related]
28. [Fetomaternal immunization against leukocytes]. Kaiser G; Keserú T; Piukovich I; Hetyey P Orv Hetil; 1972 Jan; 113(1):17-20. PubMed ID: 4621638 [No Abstract] [Full Text] [Related]
29. The association of maternal lymphocytotoxic antibodies with obstetric complications. Harris RE; Lordon RE Obstet Gynecol; 1976 Sep; 48(3):302-4. PubMed ID: 948375 [TBL] [Abstract][Full Text] [Related]
30. [Significance of immunologic conflict in the development of pregnancy complications (literature review)]. Umbrumiants DV Akush Ginekol (Mosk); 1972 Jan; 48(1):41-6. PubMed ID: 4552874 [No Abstract] [Full Text] [Related]
31. [Immunologic problems due to maternal-fetal antigenic disaffinity]. Vaglio N; Montemagno U Minerva Ginecol; 1968 May; 20(10):851-6. PubMed ID: 5736670 [No Abstract] [Full Text] [Related]
32. [Significance of Rh-negative blood in obstetrical practice]. Sidel'nikova VM Med Sestra; 1983 Aug; 42(8):3-5. PubMed ID: 6413808 [No Abstract] [Full Text] [Related]
33. Genetics in medicine: a review. Immunogenetics. Genetics of immunological deficiency states. Clarke CA; Evans DA; Harris R; McConnell RB; Woodrow JC Q J Med; 1968 Apr; 37(146):220-41. PubMed ID: 4968507 [No Abstract] [Full Text] [Related]
34. Rh immunoglobulin use with placenta previa and abruptio placentae. Grimes DA; Steele AO; Hatcher RA South Med J; 1983 Jun; 76(6):743-5, 749. PubMed ID: 6602383 [TBL] [Abstract][Full Text] [Related]
35. [Miscarriage and fetal malformations in immunologic incompatibility through the Rh-factor and ABO system]. Shileĭko VA; Verbitskaia IB Akush Ginekol (Mosk); 1975 Apr; (4):45-8. PubMed ID: 814832 [No Abstract] [Full Text] [Related]
36. [Immunological studies on gestosis. Disease caused by graft versus host reaction?]. Olivelli F Minerva Ginecol; 1978 Jun; 30(6):481-6. PubMed ID: 566880 [No Abstract] [Full Text] [Related]
37. [Tests of fetal pulmonary maturity and neonatal prognosis in normal and risk pregnancies. 3]. Ceccarello PL; Capozzi A; Zisa F; Cubesi G; Destro F; Ianniruberto A Ann Ostet Ginecol Med Perinat; 1972 Dec; 93(12):927-34. PubMed ID: 4205134 [No Abstract] [Full Text] [Related]
38. [The biological role of normal anti-A and anti-B isoagglutinins in the prolongation of the existence of mankind]. Skrzypulec Z Wiad Lek; 1970 Apr; 23(7):547-52. PubMed ID: 4989526 [No Abstract] [Full Text] [Related]
39. ABO protection in Rh immunization. Nevanlinna HR Ann Med Exp Biol Fenn; 1966; 44(2):318-21. PubMed ID: 4961011 [No Abstract] [Full Text] [Related]
40. [Sensitization of women to fetal tissue and leukocytic antigens and its role in miscarriage]. Kiseleva LF; Davydov VV; Sapankevich NG Vopr Okhr Materin Det; 1976 Jun; 21(7):65-7. PubMed ID: 969332 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]